Skip to main content

ADVERTISEMENT

Michael Adair, MBChB

The MEMORY study demonstrates the effectiveness of vortioxetine in clinically significantly improving depressive symptoms, cognitive performance, daily functioning, and HRQoL, as well as ...
10/26/2023
This study assessed the efficacy of vortioxetine versus desvenlafaxine in patients with MDD experiencing partial response to treatment with an SSRI. Vortioxetine was noninferior to desven...
10/26/2023
This subgroup analysis of the RELIEVE study evaluated effectiveness and tolerability of vortioxetine for treatment of major depressive disorder (MDD) in elderly patients. Elderly patients...
10/26/2023